Taraneh NAGHIBI, Saideh MAZLOOMZADEH, Faramarz DOBAKHTI, Sara MADANI

Simvastatin's effects on survival and outcome in traumatic braininjury patients: a comparative study

Background/aim: Mortality and morbidity still remain high in patients with traumatic brain injuries. Understanding the role of new treatments in these patients is critical. The aim of this study was to determine the effect of simvastatin on survival and outcome in traumatic brain injury patients. Materials and methods: Forty-four patients were assigned to receive either simvastatin or a placebo. The serum interleukin-6 and C-reactive protein levels were measured at the first 24 h and 48 h after trauma. All data, including the Glasgow Coma Scale score, survival at discharge, length of intensive care unit stay, and duration of mechanical ventilation, were collected. The effect of simvastatin on the collected data was then investigated. Results: The Glasgow Coma Scale level at discharge was significantly higher in the simvastatin group. The overall mortality rate, duration of mechanical ventilation, and length of intensive care unit stay were similar between the 2 groups. The C-reactive protein concentration 48 h after trauma was significantly lower in the simvastatin group, but there was no significant difference according to the interleukin-6 level 48 h after trauma between the 2 groups. Conclusion: Simvastatin could be suggested as an adjunctive therapy in traumatic brain injury patients.

PDF

___

1. Leitgeb J, Mauritz W, Brazinova A, Majdan M, Wilbacher I. Outcome after severe brain trauma associated with epidural hematoma. Arch Orthop Trauma Su 2013; 133: 199207.
2. Mercier E, Boutin A, Lauzier F, Fergusson DA, Simard JF, Zarychanski R, Moore L, McIntyre LA, Archambault P, Lamontagne F et al. Predictive value of S-100β protein for prognosis in patients with moderate and severe traumatic brain injury: systematic review and meta-analysis. Brit Med J 2013; 346: f1757.
3. Lenzlinger PM, Morganti-Kossmann MC, Laurer HL, McIntosh TK. The duality of the inflammatory response to traumatic brain injury. Mol Neurobiol 2001; 24: 169181.
4. Schmidt OI, Heyde CE, Ertel W, Stahel PF. Closed head injury an inflammatory disease? Brain Res Rev 2005; 48: 388399.
5. Ziebell JM, Morganti-Kossmann MC. Involvement of proand anti-inflammatory cytokines and chemokines in the pathophysiology of traumatic brain injury. Neurotherapeutics 2010; 7: 2230.
6. Harbi S, Tamim L, Arabi Y. Association between statin therapy and outcome in critically ill patients. BMC Clin Pharmacol 2011; 11: 1218.
7. Jansen JO, Lord JM, Thickett DR, Midwinter MJ, McAuley DF, Gao F. Clinical review: statins and trauma - a systematic review. Crit Care 2013; 17: 110.
8. Civil ID, Schwab CW. The Abbreviated Injury Scale, 1985 revision: a condensed chart for clinical use. J Trauma 1988; 28: 8790.
9. Knaus WA, Draper EA, Wagner DP, Zimmermann JE. APACHE II: a severity of disease classification system. Crit Care Med 1985; 13: 818829.
10. Hoch R, Rodriguez R, Manning T, Bishop M, Mead P, Shoemaker W, Abraham E. Effects of accidental trauma on cytokine and endotoxin production. Crit Care Med 1993; 21: 839845.
11. Meisner M, Adina H, Schmidt J. Correlation of procalcitonin and C-reactive protein to inflammation, complications, and outcome during the intensive care unit course of multipletrauma patients. Crit Care 2006; 10: R1.
12. Wang KW, Chen HJ, Lu K, Liliang PC, Liang CL, Tsai YD, Cho CL. Simvastatin attenuates the cerebral vascular endothelial inflammatory response in a rat traumatic brain injury. Ann Clin Lab Sci 2014; 44: 14550.
13. Wang KW, Wang HK, Chen HJ, Liliang PC, Liang CL, Tsai YD, Cho CL, Lu K. Simvastatin combined with antioxidant attenuates the cerebral vascular endothelial inflammatory response in a rat traumatic brain injury. Biomed Res Int 2014; 2014: 910260.
14. Sánchez-Aguilar M, Tapia-Pérez JH, Sánchez-Rodríguez JJ, Viñas-Ríos JM, Martínez-Pérez P, Cruz-Mendoza E, SánchezReyna M, Torres-Corzo JG, Gordillo-Moscoso A. Effect of rosuvastatin on cytokines after traumatic head injury. J Neurosurg 2013; 118: 669675.
15. Béziaud T, Ru Chen X, El Shafey N, Fréchou M, Teng F, Palmier B, Beray-Berthat V, Soustrat M, Margaill I, Plotkine M et al. Simvastatin in traumatic brain injury: effect on brain edema mechanisms. Crit Care Med 2011; 39: 18.
16. Tran LV. Understanding the pathophysiology of traumatic brain injury and the mechanisms of action of neuroprotective interventions. J Trauma Nurs 2014; 21: 3035.
17. Tapia-Perez J H, Rupa R, Zilke R, Gehring S, Voellger B, Schneider T. Continued statin therapy could improve the outcome after spontaneous intracerebral hemorrhage. Neurosurg Rev 2013; 36: 279287.
18. Christensen S, Thomsen RW, Johansen MB, Pedersen L, Jensen R, Larsen KM, Larsson A, Tønnesen E, Sørensen HT. Preadmission statin use and one-year mortality among patients in intensive care - a cohort study. Crit Care 2010; 14: 2029.
19. Novak V, Eisinger M, Frenkel A, Terblanche M, Adhikari NK, Douvdevani A, Amichay D, Almog Y. The effect of statin therapy on inflammatory cytokines in patients with bacterial infections. Intens Care Med 2009; 35: 12551260.
20. Morandi A, Hughes CG, Girard TD, McAuley DF, Ely EW, Pandharipande PP. Statins and brain dysfunction: a hypothesis to reduce the burden of cognitive impairment in patients who are critically ill. Chest 2011; 140: 580585.
21. Makris D, Manoulakas E, Komnos A, Papakrivou E, Tzovaras N, Hovas A, Zintzaras E, Zakynthinos E. Effect of pravastatin on the frequency of ventilator-associated pneumonia and on intensive care unit mortality: open-label, randomized study. Crit Care Med 2011; 39: 24402446.